Combination Therapy of Gemcitabine and Irinotecan in Advanced Biliary Tract Cancer: Phase II Trial

被引：0
|
作者：
Chung, Moon Jae
Park, Semi
Park, Jeong Youp
Bang, Seungmin
Park, Seung Woo
Song, Si Young
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W1896
引用
收藏
页码：S761 / S761
页数：1
相关论文
共 50 条
  • [21] Irinotecan Plus Gemcitabine and Fluorouracil in Advanced Biliary Tract Cancer: A Retrospective Study
    Endlicher, Esther
    Schnoy, Elisabeth
    Troppmann, Martina
    Rogler, Gerhard
    Messmann, Helmut
    Klebl, Frank
    Gelbmann, Cornelia
    Kullmann, Frank
    DIGESTION, 2016, 93 (03) : 229 - 233
  • [22] Gemcitabine and irinotecan combination in patients with metastatic bladder cancer: A phase II trial.
    Chaudhary, UB
    Sawhney, R
    Clark, H
    Keane, T
    Brescia, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 441S - 441S
  • [23] Phase II trial of the use of gemcitabine and 5-fluorouracil in the treatment of advanced pancreatic and biliary tract cancer
    Murad, AM
    Guimaraes, RC
    Aragao, BC
    Rodrigues, VH
    Scalabrini-Neto, AO
    Padua, CAJ
    Moore, FC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (02): : 151 - 154
  • [24] Phase II trial of the use of gemcitabine and 5-fluorouracil in the treatment of advanced pancreatic and biliary tract cancer
    Murad, AM
    DeGusmao, CB
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1041 - 1045
  • [25] Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial
    Kornek, GV
    Schuell, B
    Laengle, F
    Gruenberger, T
    Penz, M
    Karall, K
    Depisch, D
    Lang, F
    Scheithauer, W
    ANNALS OF ONCOLOGY, 2004, 15 (03) : 478 - 483
  • [26] A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
    Chen, J. S.
    Hsu, C.
    Chiang, N. J.
    Tsai, C. S.
    Tsou, H. H.
    Huang, S. F.
    Bai, L. Y.
    Chang, I. C.
    Shiah, H. S.
    Ho, C. L.
    Yen, C. J.
    Lee, K. D.
    Chiu, C. F.
    Rau, K. M.
    Yu, M. S.
    Yang, Y.
    Hsieh, R. K.
    Chang, J. Y.
    Shan, Y. S.
    Chao, Y.
    Chen, L. T.
    ANNALS OF ONCOLOGY, 2015, 26 (05) : 943 - 949
  • [27] Combining gemcitabine and capecitabine in patients with advanced biliary cancer: A phase II trial
    Knox, JJ
    Hedley, D
    Oza, A
    Feld, R
    Sin, LL
    Chen, E
    Nematollahi, M
    Pond, GR
    Zhang, J
    Moore, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) : 2332 - 2338
  • [28] Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer
    Watanabe, Akinori
    Kida, Mitsuhiro
    Miyazawa, Shiro
    Iwai, Tomohisa
    Okuwaki, Kosuke
    Kaneko, Toru
    Yamauchi, Hiroshi
    Takezawa, Miyoko
    Imaizumi, Hiroshi
    Koizumi, Wasaburo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (19) : 5979 - 5984
  • [29] Gemcitabine and cisplatin plus immunotherapy in advanced biliary tract cancer: a phase II study
    不详
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (5) : 280 - 280
  • [30] Gemcitabine and cisplatin plus immunotherapy in advanced biliary tract cancer: a phase II study
    Jordan Hindson
    Nature Reviews Gastroenterology & Hepatology, 2022, 19 : 280 - 280
12345